TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE ASSOCIATED WITH EARLY REDUCTIONS IN TISSUE INFLAMMATION: 12 WEEK RESULTS FROM A MAGNETIC RESONANCE IMAGING SUBSTUDY OF A RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Conaghan, Philip G. [1 ,2 ]
Peterfy, Charles G. [3 ]
DiCarlo, Julie [3 ]
Olech, Ewa [4 ]
Alberts, Alan R. [5 ]
Alper, Jeffrey A. [6 ]
Devenport, Jenny [7 ]
Anisfeld, Andrew M. [7 ]
Troum, Orrin M. [8 ]
机构：
[1] Univ Leeds, NIHR Leeds Biomed Res Unit, Leeds, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England
[3] Spire Sci LLC, San Francisco, CA USA
[4] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
[5] W Broward Rheumatol Associates Inc, Tamarac, FL USA
[6] Jeffrey Alper MD Res, Naples, FL USA
[7] Genentech Inc, San Francisco, CA 94080 USA
[8] USC Keck Sch Med, Santa Monica, CA USA
来源：
RHEUMATOLOGY | 2012年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 39 条
  • [21] Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal - Results from a twelve-month randomized, double-blind, placebo-controlled trial
    Quinn, MA
    Conaghan, PG
    O'Connor, PJ
    Karim, Z
    Greenstein, A
    Brown, A
    Brown, C
    Fraser, A
    Jarret, S
    Emery, P
    ARTHRITIS AND RHEUMATISM, 2005, 52 (01): : 27 - 35
  • [22] Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza (PROSA)
    Messina, Emanuele
    La Torre, Giuseppe
    Pecoraro, Martina
    Pisciotti, Martina Lucia
    Sciarra, Alessandro
    Poscia, Roberto
    Catalano, Carlo
    Panebianco, Valeria
    EUROPEAN RADIOLOGY, 2024, 34 (01) : 204 - 213
  • [23] Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials
    Glinatsi, Daniel
    Baker, Joshua F.
    Hetland, Merete L.
    Horslev-Petersen, Kim
    Ejbjerg, Bo J.
    Stengaard-Pedersen, Kristian
    Junker, Peter
    Ellingsen, Torkell
    Lindegaard, Hanne M.
    Hansen, Ib
    Lottenburger, Tine
    Moller, Jakob M.
    Ornbjerg, Lykke
    Vestergaard, Aage
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Torfing, Trine
    Moller-Bisgaard, Signe
    Axelsen, Mette B.
    Ostergaard, Mikkel
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (10) : 1707 - 1715
  • [24] LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN COMBINATION WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: 5-YEAR RESULTS FROM A 52-WEEK RANDOMIZED CONTROLLED TRIAL AND OPEN-LABEL EXTENSION STUDY
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    vanlunen, Brenda
    van der Heijde, Desiree
    RHEUMATOLOGY, 2014, 53 : 96 - 96
  • [25] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Phillip
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1455 - 1456
  • [26] Long-Term Safety and Efficacy of Certolizumab Pegol in Combination with Methotrexate in the Treatment of Rheumatoid Arthritis: 5-Year Results from a 24-Week Randomized Controlled Trial and Open-Label Extension Study
    Smolen, Josef
    Van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Strand, Vibeke
    Vencovsky, Jiri
    Schiff, Michael
    Landewe, Robert
    Haraoui, Boulos
    Walker, Susan
    van der Heijde, Desiree
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (07) : 1506 - 1507
  • [27] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S596 - S597
  • [28] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 24-Week Randomized Controlled Trial and Open-Label Extension Study
    Smolen, Josef S.
    van Vollenhoven, Ronald
    Kavanaugh, Arthur
    Strand, Vibeke
    Vencovsky, Jiri
    Schiff, Michael H.
    Landewe, Robert
    Haraoui, Boulos
    Walker, Susan
    van der Heijde, Desiree
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S988 - S989
  • [29] Fifty-two-week Results from a Phase 3, Randomized, Double-blind, Active-controlled Clinical Trial to Compare BAT1806/BIIB800, a Proposed Tocilizumab Biosimilar, with a Tocilizumab Reference Product in Subjects with Moderate to Severe RA with an Inadequate Response to Methotrexate
    Leng, Xiaomei
    Leszczynski, Piotr
    Jeka, Slawomir
    Liu, Shengyun
    Liu, Huaxiang
    Miakisz, Malgorzata
    Gu, Jieruo
    Kilasonia, Lali
    Stanislavchuk, Mykola
    Yang, Xiaolei
    Zhou, Yinbo
    Dong, Qingfeng
    Mitroiu, Marian
    Addison, Janet
    Zeng, Xiaofeng
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1813 - 1816
  • [30] Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial
    Sundin, Ulf
    Aga, Anna-Birgitte
    Skare, Oivind
    Nordberg, Lena
    Uhlig, Till
    Hammer, Hilde
    van der Heijde, Desiree
    Kvien, Tore
    Lillegraven, Siri
    Haavardsholm, Espen
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
1234